56 related articles for article (PubMed ID: 17070307)
1. Identification of nicotinamide N-methyltransferase as a novel tumor marker for renal clear cell carcinoma.
Sartini D; Muzzonigro G; Milanese G; Pierella F; Rossi V; Emanuelli M
J Urol; 2006 Nov; 176(5):2248-54. PubMed ID: 17070307
[TBL] [Abstract][Full Text] [Related]
2. Elevated Plasma Concentration of 4-Pyridone-3-carboxamide-1-β-D-ribonucleoside (4PYR) Highlights Malignancy of Renal Cell Carcinoma.
Jedrzejewska A; Jablonska P; Gawlik-Jakubczak T; Czajkowski M; Maszka P; Mierzejewska P; Smolenski RT; Slominska EM
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397036
[TBL] [Abstract][Full Text] [Related]
3. Enzymatic Fluoromethylation Enabled by the
Neti SS; Wang B; Iwig DF; Onderko EL; Booker SJ
ACS Cent Sci; 2023 May; 9(5):905-914. PubMed ID: 37252363
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide
Pozzi V; Campagna R; Sartini D; Emanuelli M
Biomolecules; 2022 Aug; 12(9):. PubMed ID: 36139012
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide N-Methyltransferase: A Promising Biomarker and Target for Human Cancer Therapy.
Li XY; Pi YN; Chen Y; Zhu Q; Xia BR
Front Oncol; 2022; 12():894744. PubMed ID: 35756670
[TBL] [Abstract][Full Text] [Related]
6. Nicotinamide-N-methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma.
Reustle A; Menig LS; Leuthold P; Hofmann U; Stühler V; Schmees C; Becker M; Haag M; Klumpp V; Winter S; Büttner FA; Rausch S; Hennenlotter J; Fend F; Scharpf M; Stenzl A; Bedke J; Schwab M; Schaeffeler E
Clin Transl Med; 2022 Jun; 12(6):e883. PubMed ID: 35678045
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review.
Togni L; Mascitti M; Sartini D; Campagna R; Pozzi V; Salvolini E; Offidani A; Santarelli A; Emanuelli M
Biomolecules; 2021 Oct; 11(11):. PubMed ID: 34827592
[TBL] [Abstract][Full Text] [Related]
8. Methylosystem for Cancer Sieging Strategy.
Tatekawa S; Ofusa K; Chijimatsu R; Vecchione A; Tamari K; Ogawa K; Ishii H
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680237
[TBL] [Abstract][Full Text] [Related]
9. Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide
Campagna R; Pozzi V; Sartini D; Salvolini E; Brisigotti V; Molinelli E; Campanati A; Offidani A; Emanuelli M
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638427
[TBL] [Abstract][Full Text] [Related]
10. The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update.
Campagna R; Pozzi V; Spinelli G; Sartini D; Milanese G; Galosi AB; Emanuelli M
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439880
[TBL] [Abstract][Full Text] [Related]
11. Macrocyclic Peptides as a Novel Class of NNMT Inhibitors: A SAR Study Aimed at Inhibitory Activity in the Cell.
Hayashi K; Uehara S; Yamamoto S; Cary DR; Nishikawa J; Ueda T; Ozasa H; Mihara K; Yoshimura N; Kawai T; Ono T; Yamamoto S; Fumoto M; Mikamiyama H
ACS Med Chem Lett; 2021 Jul; 12(7):1093-1101. PubMed ID: 34267879
[TBL] [Abstract][Full Text] [Related]
12. Nicotinamide N-Methyltransferase Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric Cancer.
Wu M; Hu W; Wang G; Yao Y; Yu XF
Front Genet; 2020; 11():580299. PubMed ID: 33193702
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal Stem Cells in the Adult Human Liver: Hype or Hope?
Kholodenko IV; Kurbatov LK; Kholodenko RV; Manukyan GV; Yarygin KN
Cells; 2019 Sep; 8(10):. PubMed ID: 31546729
[TBL] [Abstract][Full Text] [Related]
14. Nicotinamide N‑methyltransferase induces the proliferation and invasion of squamous cell carcinoma cells.
Hah YS; Cho HY; Jo SY; Park YS; Heo EP; Yoon TJ
Oncol Rep; 2019 Nov; 42(5):1805-1814. PubMed ID: 31545452
[TBL] [Abstract][Full Text] [Related]
15. Bisubstrate Inhibitors of Nicotinamide
Gao Y; van Haren MJ; Moret EE; Rood JJM; Sartini D; Salvucci A; Emanuelli M; Craveur P; Babault N; Jin J; Martin NI
J Med Chem; 2019 Jul; 62(14):6597-6614. PubMed ID: 31265285
[TBL] [Abstract][Full Text] [Related]
16. Citrullination Inactivates Nicotinamide- N-methyltransferase.
Nemmara VV; Tilvawala R; Salinger AJ; Miller L; Nguyen SH; Weerapana E; Thompson PR
ACS Chem Biol; 2018 Sep; 13(9):2663-2672. PubMed ID: 30044909
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of nicotinamide N-methyltransferase in HSC-2 OSCC cell line: effect on apoptosis and cell proliferation.
Seta R; Mascitti M; Campagna R; Sartini D; Fumarola S; Santarelli A; Giuliani M; Cecati M; Muzio LL; Emanuelli M
Clin Oral Investig; 2019 Feb; 23(2):829-838. PubMed ID: 29882109
[TBL] [Abstract][Full Text] [Related]
18. Nicotinamide N-methyltransferase promotes epithelial-mesenchymal transition in gastric cancer cells by activating transforming growth factor-β1 expression.
Liang L; Zeng M; Pan H; Liu H; He Y
Oncol Lett; 2018 Apr; 15(4):4592-4598. PubMed ID: 29541230
[TBL] [Abstract][Full Text] [Related]
19. Combination of mTOR and MAPK Inhibitors-A Potential Way to Treat Renal Cell Carcinoma.
Chauhan A; Semwal DK; Mishra SP; Goyal S; Marathe R; Semwal RB
Med Sci (Basel); 2016 Oct; 4(4):. PubMed ID: 29083380
[TBL] [Abstract][Full Text] [Related]
20. NNMT Silencing Activates Tumor Suppressor PP2A, Inactivates Oncogenic STKs, and Inhibits Tumor Forming Ability.
Palanichamy K; Kanji S; Gordon N; Thirumoorthy K; Jacob JR; Litzenberg KT; Patel D; Chakravarti A
Clin Cancer Res; 2017 May; 23(9):2325-2334. PubMed ID: 27810903
[No Abstract] [Full Text] [Related]
[Next] [New Search]
